NURS 6630 FINAL EXAM 5 – QUESTION AND ANSWERS

NURS 6630 FINAL EXAM 5 – QUESTION AND
ANSWERS

 Question 1
1 out of 1 points
Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP
prescribe for Mrs. Rosen to improve this condition?



Selected D.
Answer: All of the
above

 Question 2
0 out of 1 points
An elderly woman with a history of Alzheimer’s disease, coronary artery disease, and
myocardial infarction had a fall at home 3 months ago that resulted in her receiving an
open reduction internal fixation. While assessing this patient, the PMHNP is made aware
that the patient continues to experience mild to moderate pain. What is the PMHNP most
likely to do?



Selected A.
Answer: Order an X-ray because it is possible that she
dislocated her hip.


 Question 3
1 out of 1 points
The PMHNP is caring for a patient who reports excessive arousal at nighttime. What could
the PMHNP use for a time-limited duration to shift the patient’s brain from a hyperactive
state to a sleep state?



Selected B.
Answer: Benzodiazepi
nes



 Question 4
1 out of 1 points
A patient addicted to heroin is receiving treatment for detoxification. He begins to
experience tachycardia, tremors, and diaphoresis. What medication will the PMHNP
prescribe for this patient?

, Selected D.
Answer: Clonidine
(Catapres)

 Question 5
1 out of 1 points
The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic pain. How does the
PMHNP anticipate the drug to work?



Selected A.
Answer: It will bind to the alpha-2-delta ligand subunit of voltage-sensitive
calcium channels.



 Question 6
1 out of 1 points
A patient with hypersexual disorder is being assessed for possible pharmacologic
treatment. Why does the PMHNP prescribe an antiandrogen for this patient?



Selected C.
Answer: It will block
testosterone.




 Question 7
1 out of 1 points
Which statement best describes a pharmacological approach to treating patients for
impulsive aggression?



Selected D.
Answer: Opioid antagonists can be used to
reduce drive.

 Question 8
1 out of 1 points
A 26-year-old female patient with nicotine dependence and a history of anxiety presents
with symptoms of attention deficit hyperactivity disorder (ADHD). Based on the
assessment, what does the PMHNP consider?


Selected A.
Answer: ADHD is often not the focus of treatment in adults with
comorbid conditions.

,  Question 9
1 out of 1 points
A patient with irritable bowel syndrome reports chronic stomach pain. The PMHNP wants
to prescribe the patient an agent that will cause irrelevant nociceptive inputs from the
pain to be ignored and no longer perceived as painful. Which drug will the PMHNP
prescribe?


Selected C.
Answer: Duloxetine
(Cymbalta)



 Question 10
1 out of 1 points
Parents of a 12-year-old boy want to consider attention deficit hyperactivity disorder
(ADHD) medication for their son. Which medication would the PMHNP start?



Selected All of the above could potentially treat their
Answer: son’s symptoms.

 Question 11
1 out of 1 points
Which of the following is a true statement regarding the use of stimulants to treat
attention deficit hyperactivity disorder (ADHD)?


Selected B.
Answer: Signal strength output is increased by dialing up the release of
dopamine (DA) and norepinephrine (NE).




 Question 12
1 out of 1 points
Mr. Peterson is meeting with the PMHNP to discuss healthier dietary habits. With a BMI of
33, Mr. Peterson is obese and needs to modify his food intake. “Sometimes I think I’m
addicted to food the way some people are addicted to drugs,” he says. Which statement
best describes the neurobiological parallels between food and drug addiction?


Selected A.
Answer: There is decreased activation of the
prefrontal cortex.